ヨーロッパの幹細胞製造市場 – 業界動向と2028年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Medical Devices ヨーロッパの幹細胞製造市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパの幹細胞製造市場 – 業界動向と2028年までの予測

  • Medical Devices
  • Published Report
  • Aug 2021
  • Europe
  • 350 ページ
  • テーブル数: 186
  • 図の数: 36
Buy Now 今すぐ購入

ヨーロッパの幹細胞製造市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
 2021 –2028
Diagram 市場規模（基準年）
 USD 11,076.78 Million
Diagram Market Size (Forecast Year)
 USD 23,505.08 Million
Diagram CAGR
 %
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>ヨーロッパの幹細胞製造市場、製品別（幹細胞株、器具、消耗品、キット）、用途別（研究用途、臨床用途、細胞および組織バンキングなど）、エンドユーザー別（バイオテクノロジーおよび製薬会社、研究機関および学術機関、細胞バンクおよび組織バンク、病院および外科センターなど）、流通チャネル別（直接販売およびサードパーティ販売代理店）、国別（ドイツ、フランス、英国、イタリア、スペイン、ロシア、ベルギー、トルコ、スイス、オランダ、その他のヨーロッパ諸国）2028年までの業界動向および予測。   

欧州の幹細胞製造市場市場分析と洞察: ヨーロッパの幹細胞製造市場

ヨーロッパの幹細胞製造市場は、2021年から2028年の予測期間に市場が成長すると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に10.1％のCAGRで成長し、2020年の110億7678万米ドルから2028年には235億508万米ドルに達すると分析しています。がんや幹細胞移植の罹患率の上昇、幹細胞移植に関する新たな技術進歩の成長は、予測期間における市場の需要を推進する主要な原動力となる可能性があります。

幹細胞は、さまざまな細胞に分化できる体の原材料です。つまり、特殊な機能を持つ他のすべての細胞が生成される細胞です。幹細胞療法は、同種療法および自己療法のための胚性幹細胞、成体幹細胞を含むあらゆる種類のヒト幹細胞を使用する病状の治療として定義されます。

幹細胞研究の出現により、幹細胞とその誘導体の治療効果が明らかになりました。幹細胞とその誘導体の製造の成功は、ヘルスケアの分野にプラスの影響を与えています。これらの幹細胞製品は、損傷した組織や臓器の機能を回復し、がん、血液疾患、遺伝性疾患、自己免疫疾患、炎症性疾患の治療のための幹細胞ベースの細胞療法を開発するために使用されます。

革新的な製品の開発に向けた主要な業界プレーヤーによる研究開発の増加、政府による支援、幹細胞の採用の増加が、市場の成長を牽引しています。この分野に存在する高度な方法論も、世界の幹細胞製造市場の成長を促進しています。ただし、治療費の高さ、腫瘍治療の代替手段の可用性が市場を抑制する可能性があります。多数のパイプライン製品の存在と、市場プレーヤーによる戦略的イニシアチブは、市場にとってチャンスとなっています。熟練した専門家の不足は、市場にとって課題となる可能性があります。

世界の幹細胞製造市場レポートでは、市場シェア、新しい開発、国内および現地の市場プレーヤーの影響の詳細を提供し、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から機会を分析します。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、収益に影響を与えるソリューションを作成し、希望する目標を達成できるようお手伝いします。

欧州の幹細胞製造市場幹細胞製造市場の範囲と市場規模

幹細胞製造市場は、製品、アプリケーション、エンドユーザー、流通チャネルに基づいて 4 つの主要なセグメントに分類されます。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コア アプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

  • 製品に基づいて、幹細胞製造市場は幹細胞株、機器、消耗品およびキットに分類されます。2021年には、消耗品の頻繁な購入、幹細胞研究の増加、幹細胞治療の需要の増加により、消耗品およびキットセグメントが市場を支配すると予想されます。
  • アプリケーションに基づいて、細胞製造市場は研究アプリケーション、臨床アプリケーション、細胞および組織バンキング、その他に分類されます。 2021年には、幹細胞細胞学および病態生理学研究への注目が高まり、幹細胞製品の開発と商業化を支援するための官民資金が増加しているため、研究アプリケーションセグメントが市場を支配すると予想されます。
  • エンドユーザーに基づいて、幹細胞製造市場は、バイオテクノロジーおよび製薬会社、研究機関および学術機関、細胞バンクおよび組織バンク、病院および外科センター、その他に分類されます。 2021年には、製薬会社およびバイオテクノロジー会社による幹細胞研究の能力拡大に向けた戦略的取り組み（買収、パートナーシップ、コラボレーションなど）の重要性が高まっているため、製薬会社およびバイオテクノロジー会社セグメントが市場を支配すると予想されます。
  • 流通チャネルに基づいて、幹細胞製造市場は直接販売とサードパーティの販売代理店に分割されます。 2021年には、市場に多数のプレーヤーが存在するため、直接販売セグメントが市場を支配すると予想されます。

ヨーロッパの幹細胞製造市場の国別分析

幹細胞製造市場が分析され、製品、アプリケーション、エンドユーザー、流通チャネル別に市場規模の情報が提供されます。

北米の幹細胞製造市場レポートで取り上げられている国は、ドイツ、フランス、英国、イタリア、スペイン、ロシア、ベルギー、トルコ、スイス、オランダ、その他のヨーロッパ諸国です。

ドイツは、幹細胞ベースの製品に関する未開拓の機会が存在し、またドイツにおける癌の罹患率が増加しているため、ヨーロッパ地域の世界の幹細胞製造市場を独占しています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。  

幹細胞療法の採用拡大と官民資金の投入により、幹細胞製造市場にチャンスが生まれています。  

幹細胞製造市場では、創傷デブリードマン装置の売上、ELISpot および FluorSpot アッセイの進歩の影響、ELISpot および FluorSpot アッセイ市場へのサポートに関する規制シナリオの変化など、各国の特定産業の成長に関する詳細な市場分析も提供されます。データは 2019 年から 2020 年の履歴期間について利用可能です。

競争環境と欧州幹細胞製造市場シェア分析

ヨーロッパの幹細胞製造市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、幹細胞製造市場に関連する会社の焦点にのみ関連しています。

幹細胞製造を提供する主要企業としては、Thermo Fisher Scientific Inc.、Merck KGaA、BD、Organogenesis Inc.、Vericel Corporation、ANTEROGEN. CO., LTD.、VistaGen Therapeutics, Inc.、FUJIFILM Cellular Dynamics, Inc.、American CryoSystem Corporation、PromoCell GmbH、Sartorius AG、ViaCyte, Inc.、STEM CELL Technologies, Inc.、武田薬品工業株式会社、第一三共株式会社、Bio-Techne、REPROCELL Inc.、Catalent, Inc、Mesoblast Ltd、アステラス製薬株式会社などがあります。

市場プレーヤーによる戦略的取り組みと幹細胞製造における新たな技術進歩により、さまざまな治療法のギャップが埋められています。

例えば、

  • 2021年6月、REPROCELL Inc.は、iPSC由来のマスター細胞バンクの需要増加に対応するため、新しいシードiPSC製造スイートを開設したことを発表しました。これにより、同社は今後数年間で高まる需要に対応し、成長することができます。
  • 2021年6月、Catalent Inc.は、ヒト人工多能性幹細胞の製造業者であるRheinCell Therapeuicsを買収したことを発表しました。これにより、同社は既存のカスタム細胞治療プロセス開発を強化することができます。
  • 2021年6月、バイオテクネは遺伝子工学および細胞・遺伝子治療の製造能力を強化したと発表しました。これにより、同社はさらに事業を拡大することができます。

市場プレーヤーによるコラボレーション、ジョイントベンチャー、およびその他の戦略により、幹細胞製造市場における企業市場が強化され、組織が幹細胞製造市場向けの提供を改善するメリットももたらされます。

 

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe stem cell manufacturing market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCTs LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. EUROPE STEM CELL MANUFACTURING MARKET: REGULATIONS
    1. REGULATORY FRAMEWORK IN THE UNITED STATES
    2. REGULATORY FRAMEWORK IN EUROPE
    3. REGULATORY FRAMEWORK IN INDIA
    4. REGULATORY FRAMEWORK IN JAPAN
  6. pestel analysis
  7. porters five forces
  8. Market Overview
    1. Drivers
      1. INCREASING PREVaLENCE OF CANCEr
      2. INCREASE INVESTMENT IN R & D
      3. increasing adoption of stem cell therapy
      4. growing biotechnology sector, along with rising healthcare expenditure
    2. restrainTs
      1. high cost associated with therapies
      2. availability of alternatives for tumor treatment
      3. adverse effects of stem cell transplant
    3. opportunities
      1. presence of pipeline products
      2. strategic initiatives by market players
      3. rising healthcare infrastructure by various countries
      4. increasing interest for personalized medicine
    4. challenges
      1. LACK OF skilled professionals
      2. STRINGENT REGULATIONs
  9. IMPACT OF COVID-19 ON EUROPE STEM CELL MANUFACTURING MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
    5. CONCLUSION
  10. Europe stem cell manufacturing market, By products
    1. overview
    2. consumables & kits
      1. Culture Media
      2. differentiation kits
      3. stem cell antibody arrays
      4. identification kits
      5. stem cell antibody panels
      6. stem cell primer pair panels
      7. Cytokine panels for hematopoietic stem cell expansion
      8. lineage depletion antibodies & kits
      9. others
    3. stem cell lines
      1. human cell systems
        1. INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
        2. MESENCHYMAL STEM CELLS
        3. PRIMARY HUMAN CELLS
          1. FIBROBLAST
          2. EPITHELIAL
          3. ENDOTHELIAL
        4. HEMATOPOIETIC STEM CELLS
        5. NEURAL STEM CELLS
        6. CARDIAC STEM CELLS
        7. PANCREATIC STEM CELLS
        8. OTHERS
      2. rodent cell systems
        1. PLURIPOTENT MOUSE ES CELLS
        2. MOUSE EMBRYO CULTURE
        3. PMEFS
        4. MULTIPOTENT RODENT STEM CELLS
        5. MESENCHYMAL STEM CELLS
        6. NEURAL STEM CELLS
        7. OTHERS
    4. instruments
      1. BIOREACTORS & INCUBATORS
      2. cell sorters
      3. others
  11. Europe STEM CELL MANUFACTURING market, By APPLICATION
    1. overview
    2. research applications
      1. lIFE SCIENCE RESEARCH
      2. drug discovery AND development
    3. clinical applications
      1. ALLOGENIC STEM CELL THERAPY
        1. SURGERIES
        2. MUSCULOSKELETAL DISORDERS
        3. WOUNDS AND INJURIES
        4. ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
        5. OTHERS
      2. AUTOLOGOUS STEM CELL THERAPY
        1. WOUNDS & INJURIES
        2. CARDIOVASCULAR DISEASES
        3. GASTROINTESTINAL DISEASES
        4. OTHERS
    4. cell & tissue banking
    5. others
  12. Europe STEM CELL MANUFACTURING market, By END USER
    1. overview
    2. biotechnology & pharmaceutical companies
    3. RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
    4. cell banks & tissue banks
    5. hospitals & surgical centers
    6. others
  13. Europe stem cell manufacturing market, By distribution channel
    1. overview
    2. DIRECT sales
    3. third party distributors
  14. EUROPE stem cell manufacturing MARKET, BY REGION
    1. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Netherlands
      6. Switzerland
      7. Spain
      8. Russia
      9. Belgium
      10. Turkey
      11. Rest of Europe
  15. EUROPE Stem Cell Manufacturing Market: COMPANY landscape
    1. company share analysis: Europe
  16. swot analysis
  17. company profile
    1. THERMO FISHER SCIENTIFIC INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. takeda pharmaceutical company limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Merck kgaa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. AMERICAN cryosystem corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. ANTEROGEN.CO.,LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. astellas pharma inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. BD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    8. Bio-TECHNE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. catalent, inc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. daiichi sankyo company, limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. fujifilm cellular dynamics, inc.
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. Product Portfolio
      4. Recent Developments
    12. mesoblast ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. organogenesis inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. promocell gmbh
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    15. reprocell inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. sartorius ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. stemcell technologies inc.
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    18. vericel corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. viacyte, inc.
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    20. vistagen therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  18. questionnaire
  19. related reports

表のリスト

TABLE 1 Below provided are the alternatives for cancer treatment:

TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 3 EUROPE stem cell manufacturing MARKET, By products, 2019-2028 (USD million)

TABLE 4 Europe consumables & kits in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 5 EUROPE consumables & kits in stem cell manufacturing MARKET, By products, 2019-2028 (USD million)

TABLE 6 Europe stem cell lines in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 7 Europe stem cell lines in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 8 Europe human cell systems in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 9 Europe primary human cells in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 10 Europe rodent cell systems in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 11 Europe instruments in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 12 Europe instruments in stem cell manufacturing Market, By PRODUCT, 2019-2028 (USD Million)

TABLE 13 Europe stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 14 Europe research applications in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 15 Europe research applications in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 16 Europe clinical applications in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 17 Europe clinical applications in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 18 Europe allogenic stem cell therapy in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 19 Europe autologous stem cell therapy in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 20 Europe cell & tissue banking in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 21 Europe others in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 22 Europe stem cell manufacturing Market, By end user, 2019-2028 (USD Million)

TABLE 23 Europe biotechnology & pharmaceuticaL COMPANIES IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 24 Europe research institutes and academic institutes IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 25 Europe cell banks & tissue banks IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 26 Europe hospitals & surgical centers IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 27 Europe others IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 28 Europe stem cell manufacturing Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)

TABLE 29 Europe Direct sales in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 30 Europe third party distributors in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 31 Europe Stem Cell Manufacturing Market, By country, 2019-2028 (USD Million)

TABLE 32 EUROPE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 33 Europe Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 34 Europe Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 35 Europe Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 36 Europe Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 37 Europe Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 38 Europe Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 39 Europe Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 40 Europe Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 41 Europe Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 42 Europe Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 43 Europe Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 44 Europe Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 45 Europe Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 46 GERMANY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 47 Germany Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 48 Germany Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 49 Germany Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 50 Germany Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 51 Germany Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 52 Germany Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 53 Germany Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 54 Germany Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 55 Germany Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 56 Germany Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 57 Germany Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 58 Germany Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 59 Germany Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 FRANCE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 61 France Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 62 France Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 63 France Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 64 France Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 65 France Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 66 France Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 67 France Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 68 France Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 69 France Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 70 France Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 71 France Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 72 France Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 73 France Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 74 U.K. STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 75 U.K. Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 76 U.K. Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 77 U.K. Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 78 U.K. Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 79 U.K. Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 80 U.K. Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 81 U.K. Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 82 U.K. Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 83 U.K. Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 84 U.K. Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 85 U.K. Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 86 U.K. Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 87 U.K. Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 88 ITALY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 89 Italy Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 90 Italy Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 91 Italy Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 92 Italy Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 93 Italy Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 94 Italy Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 95 Italy Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 96 Italy Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 97 Italy Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 98 Italy Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 99 Italy Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 100 Italy Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 101 Italy Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 102 NETHERLAND STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 103 Netherland Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 104 Netherland Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 105 Netherland Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 106 Netherland Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 107 Netherland Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 108 Netherland Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 109 Netherland Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 110 Netherland Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 111 Netherland Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 112 Netherland Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 113 Netherland Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 114 Netherland Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 115 Netherland Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 116 SWITZERLAND STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 117 Switzerland Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 118 Switzerland Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 119 Switzerland Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 120 Switzerland Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 121 Switzerland Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 122 Switzerland Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 123 Switzerland Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 124 Switzerland Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 125 Switzerland Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 126 Switzerland Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 127 Switzerland Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 128 Switzerland Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 129 Switzerland Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 130 SPAIN STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 131 Spain Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 132 Spain Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 133 Spain Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 134 Spain Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 135 Spain Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 136 Spainstruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 137 Spain Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 138 Spain Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 139 Spain Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 140 Spain Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 141 Spain Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 142 Spain Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 143 Spain Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 144 RUSSIA STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 145 Russia Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 146 Russia Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 147 Russia Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 148 Russia Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 149 Russia Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 150 Russia Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 151 Russia Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 152 Russia Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 153 Russia Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 154 Russia Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 155 Russia Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 156 Russia Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 157 Russia Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 158 BELGIUM STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 159 Belgium Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 160 Belgium Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 161 Belgium Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 162 Belgium Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 163 Belgium Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 164 Belgium Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 165 Belgium Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 166 Belgium Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 167 Belgium Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 168 Belgium Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 169 Belgium Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 170 Belgium Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 171 Belgium Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 172 TURKEY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 173 Turkey Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 174 Turkey Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 175 Turkey Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 176 Turkey Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 177 Turkey Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 178 Turkey Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 179 Turkey Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 180 Turkey Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 181 Turkey Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 182 Turkey Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 183 Turkey Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 184 Turkey Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 185 Turkey Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 186 REST OF EUROPE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

図表一覧

FIGURE 1 Europe stem cell manufacturing market: segmentation

FIGURE 2 Europe stem cell manufacturing market: data triangulation

FIGURE 3 Europe stem cell manufacturing market: DROC ANALYSIS

FIGURE 4 Europe stem cell manufacturing market : Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 Europe stem cell manufacturing market : COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe stem cell manufacturing market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe stem cell manufacturing market: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE stem cell manufacturing MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 Europe stem cell manufacturing market: vendor share analysis

FIGURE 10 Europe stem cell manufacturing market: SEGMENTATION

FIGURE 11 increasing adoption of stem cell therapy is expected to drive THE Europe stem cell manufacturing market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 consumables & kits segment is expected to account for the largest share of the Europe stem cell manufacturing market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTs, OPPORTUNITIES AND CHALLENGES OF EUROPE stem cell manufacturing MARKET

FIGURE 14 New Cancer Cases Worldwide in 2018

FIGURE 15 EUROPE stem cell manufacturing MARKET, By products, 2020

FIGURE 16 EUROPE stem cell manufacturing MARKET: BY products, 2021-2028 (USD million )

FIGURE 17 EUROPE stem cell manufacturing MARKET: BY products, CAGR (2021-2028)

FIGURE 18 EUROPE stem cell manufacturing MARKET: BY products, LIFELINE CURVE

FIGURE 19 EUROPE stem cell manufacturing MARKET, By application, 2020

FIGURE 20 EUROPE stem cell manufacturing MARKET: BY application, 2021-2028 (USD million )

FIGURE 21 EUROPE stem cell manufacturing MARKET: BY application, CAGR (2021-2028)

FIGURE 22 EUROPE stem cell manufacturing MARKET: BY application, LIFELINE CURVE

FIGURE 23 EUROPE stem cell manufacturing MARKET, By end user, 2020

FIGURE 24 EUROPE stem cell manufacturing MARKET: BY end user, 2021-2028 (USD million )

FIGURE 25 EUROPE stem cell manufacturing MARKET: BY end user, CAGR (2021-2028)

FIGURE 26 EUROPE stem cell manufacturing MARKET: BY end user, LIFELINE CURVE

FIGURE 27 EUROPE stem cell manufacturing MARKET, By distribution channel, 2020

FIGURE 28 EUROPE stem cell manufacturing MARKET: BY distribution channel, 2021-2028 (USD million )

FIGURE 29 EUROPE stem cell manufacturing MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 30 EUROPE stem cell manufacturing MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 31 EUROPE Stem Cell Manufacturing Market: SNAPSHOT (2020)

FIGURE 32 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2020)

FIGURE 33 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2021 & 2028)

FIGURE 34 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2020 & 2028)

FIGURE 35 EUROPE STEM CELL MANUFACTURING Market: BY Products (2021-2028)

FIGURE 36 Europe Stem Cell Manufacturing Market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The market is segmented based on , By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (Germany, France, U.K., Italy, Spain, Russia, Belgium, Turkey, Switzerland, Netherlands, and Rest of Europe ) Industry Trends and Forecast to 2028.    .
The Europe Stem Cell Manufacturing Market size was valued at USD 11076.78 USD Million in 2020.
The Europe Stem Cell Manufacturing Market is projected to grow at a CAGR of 10.1% during the forecast period of 2021 to 2028.

関連ページを閲覧する

Banner